Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations-Reference-Cited by-同舟云学术

Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations

Published:2018-03-01 Issue:5 Volume:100 Page:395-402
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Moiseev Ivan S.¹^ORCID,Pirogova Olga V.¹,Alyanski Alexandr L.¹,Babenko Elena V.¹,Gindina Tatyana L.¹,Darskaya Elena I.¹,Slesarchuk Olga A.¹,Bykova Tatyana A.¹,Chukhlovin Alexei B.¹,Pevtcov Dmitrii E.¹,Bondarenko Sergey N.¹,Afanasyev Boris V.¹

Affiliation:

1. R.M. Gorbacheva Memorial Institute of Hematology, Oncology and Transplantation; Pavlov First Saint Petersburg State Medical University; Saint Petersburg Russian Federation

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13030/fullpdf

Reference48 articles.

1. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial;Storb;Blood,1989

2. Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European group for blood and marrow transplantation;Ruutu;Bone Marrow Transplant,2012

3. Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan;Yanada;Bone Marrow Transplant,2004

4. Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia;Craddock;Haematologica,2010

5. Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation;Ram;Biol Blood Marrow Transplant,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT;Bone Marrow Transplantation;2024-01-22

2. Impact of Post-transplant cyclophosphamide (PTCy)-Based Prophylaxis in Matched Sibling Donor Allogeneic Haematopoietic Cell Transplantation for Patients with Myelodysplastic Syndrome: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of the EBMT;2023-09-09

3. Case Series Using Salvage Haplo-Identical Stem Cells for Secondary Transplantation;Medicina;2023-06-02

4. An analysis of the efficacy of graft-versus-host disease prophylaxis with post-transplant cyclophosphamide in children with acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation from HLA-matched and partially-matched unrelated donors;Pediatric Hematology/Oncology and Immunopathology;2023-05-12

5. First-line steroid-free systemic treatment of acute and chronic graft-versus-host disease after novel prophylaxis regimens;Bone Marrow Transplantation;2022-11-30